Insmed Inc. buy Guggenheim
Start price
05.09.23
/
50%
€24.60
Target price
05.09.24
€48.49
Performance (%)
164.23%
End price
06.09.24
€65.00
Summary
This prediction ended on 06.09.24 with a price of €65.00. The BUY prediction by Guggenheim for Insmed Inc. saw massive gains of 164.23%. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Insmed Inc. | 0.000% | 0.000% | 168.595% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $50.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten